Panel Discussion: Advancing Digital Biomarkers for Neurodegenerative Diseases
Time: 1:00 pm
day: One-Day Digital Content
This panel discussion aims to discuss the strengths and limitations of digital health technologies, the opportunities and risks associated with this emerging business ecosystem, and how these technological advances in combination may lead to reframing the types of questions to pose.
- Digital phenotyping as the first step to identifying and validating digital biomarkers
- Discuss how to build the right infrastructure needed to drive innovation in digital biomarker discovery
- Hardware, Software and Data challenges
- Driving forward to a vision of AD precision medicine and AD prevention